ONTOLOGY REPORT - ANNOTATIONS
Term: Carcinoma, Non-Small-Cell Lung
Accession: RDO:0005126
browse the term
Definition: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.
Synonyms: exact_synonym: Non-Small Cell Lung Cancer; Non-Small-Cell Lung Carcinomas; Nonsmall Cell Lung Cancer
primary_id: MESH:D002289
Carcinoma, Non-Small-Cell Lung
G
Ager
advanced glycosylation end product-specific receptor
ISS
20
4,250,613
4,253,540
RGD:7245515
RGD
G
Akt1
v-akt murine thymoma viral oncogene homolog 1
ISS
6
137,640,482
137,657,552
RGD:5133243
RGD
G
Braf
v-raf murine sarcoma viral oncogene homolog B1
ISS
4
67,117,759
67,243,058
RGD:5133243
RGD
G
Braf
v-raf murine sarcoma viral oncogene homolog B1
ISS
4
67,117,759
67,243,058
RGD:5133242
RGD
G
Cda
cytidine deaminase
ISS
5
157,117,303
157,143,989
RGD:2316365
RGD
G
Cdh13
cadherin 13
ISS
19
48,507,173
49,575,123
RGD:2293545
RGD
G
Chi3l1
chitinase 3-like 1 (cartilage glycoprotein-39)
Severity
ISS
13
47,139,658
47,147,591
RGD:4892660
RGD
G
Cmpk1
cytidine monophosphate (UMP-CMP) kinase 1
Severity
ISS
5
135,320,845
135,348,973
RGD:5133252
RGD
G
Egfr
epidermal growth factor receptor
ISS
14
97,617,358
97,788,211
RGD:5133241
RGD
G
Egfr
epidermal growth factor receptor
ISS
14
97,617,358
97,788,211
RGD:5131629
RGD
G
Egfr
epidermal growth factor receptor
ISS
14
97,617,358
97,788,211
RGD:5133242
RGD
G
Egfr
epidermal growth factor receptor
ISS
14
97,617,358
97,788,211
RGD:1601010
RGD
G
Egfr
epidermal growth factor receptor
Susceptibility
ISS
14
97,617,358
97,788,211
RGD:5131640
RGD
G
Egr1
early growth response 1
Resistance
ISS
18
27,343,919
27,346,117
RGD:5131925
RGD
G
Ephx1
epoxide hydrolase 1, microsomal (xenobiotic)
Disease_progression
ISS
13
96,722,973
96,752,940
RGD:4889124
RGD
G
Erbb2
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
ISS
10
87,219,157
87,242,919
RGD:5133243
RGD
G
Esr1
estrogen receptor 1
ISS
1
35,523,680
35,759,891
RGD:4892255
RGD
G
Gstp1
glutathione S-transferase pi 1
Susceptibility
ISS
1
206,627,398
206,629,866
RGD:4140944
RGD
G
Gstp1
glutathione S-transferase pi 1
ISS
1
206,627,398
206,629,866
RGD:4140950
RGD
G
Icam1
intercellular adhesion molecule 1
Disease_progression
ISS
8
20,040,177
20,051,939
RGD:4145465
RGD
G
Il18
interleukin 18
ISS
8
53,936,584
53,943,228
RGD:4889836
RGD
G
Il1a
interleukin 1 alpha
ISS
3
116,913,612
116,924,114
RGD:4142793
RGD
G
Il1b
interleukin 1 beta
Susceptibility
ISS
3
116,964,422
116,970,867
RGD:4143167
RGD
G
Il1rn
interleukin 1 receptor antagonist
Susceptibility
ISS
3
2,607,800
2,613,216
RGD:4143167
RGD
G
Irf1
interferon regulatory factor 1
ISS
10
39,220,600
39,227,602
RGD:1600014
RGD
G
Itgb3
integrin, beta 3
ISS
RGD:5037228
RGD
G
Kras
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
ISS
4
182,869,242
182,895,106
RGD:5133242
RGD
G
Lep
leptin
ISS
4
55,943,837
55,945,938
RGD:5128815
RGD
G
Lta
lymphotoxin alpha (TNF superfamily, member 1)
ISS
20
3,657,842
3,659,848
RGD:4143264
RGD
G
Ltf
lactotransferrin
ISS
8
115,417,764
115,440,609
RGD:7243860
RGD
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
Susceptibility
ISS
8
112,111,358
112,113,311
RGD:1599219
RGD
G
Map2k1
mitogen activated protein kinase kinase 1
ISS
8
68,379,074
68,451,554
RGD:5133243
RGD
G
Map2k1
mitogen activated protein kinase kinase 1
ISS
8
68,379,074
68,451,554
RGD:5133242
RGD
G
Met
met proto-oncogene
ISS
4
43,134,183
43,211,355
RGD:5133242
RGD
G
Met
met proto-oncogene
ISS
4
43,134,183
43,211,355
RGD:5133241
RGD
G
Met
met proto-oncogene
ISS
4
43,134,183
43,211,355
RGD:5133243
RGD
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
ISS
20
13,191,986
13,192,851
RGD:4891022
RGD
G
Mmp7
matrix metallopeptidase 7
ISS
8
4,526,018
4,533,730
RGD:5129528
RGD
G
Mmp9
matrix metallopeptidase 9
Disease_progression
IEP
3
155,985,473
155,993,433
RGD:5129215
RGD
G
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
Susceptibility
ISS
16
23,855,555
23,876,531
RGD:4140950
RGD
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
Disease_progression
ISS
19
37,251,147
37,266,040
RGD:5133265
RGD
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
ISS
19
37,251,147
37,266,040
RGD:5133268
RGD
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISS
2
118,640,277
118,672,440
RGD:5133243
RGD
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISS
2
118,640,277
118,672,440
RGD:5133242
RGD
G
Plau
plasminogen activator, urokinase
ISS
15
3,680,072
3,686,232
RGD:4892055
RGD
G
Pten
phosphatase and tensin homolog
ISS
1
236,771,027
236,837,261
RGD:5133242
RGD
G
Ptges
prostaglandin E synthase
Severity
ISS
3
9,946,194
9,957,538
RGD:5135302
RGD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
Severity
ISS
13
64,427,288
64,432,978
RGD:5135471
RGD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
Severity
ISS
13
64,427,288
64,432,978
RGD:5135302
RGD
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISS
1
208,262,669
208,273,148
RGD:2298765
RGD
G
Robo1
roundabout, axon guidance receptor, homolog 1 (Drosophila)
IEP
11
10,784,947
11,720,646
RGD:2314868
RGD
G
Scgb3a2
secretoglobin, family 3A, member 2
ISS
18
37,200,474
37,203,396
RGD:5147390
RGD
G
Sftpd
surfactant protein D
Disease_progression
ISS
RGD:4143490
RGD
G
Spp1
secreted phosphoprotein 1
ISS
RGD:1581361
RGD
G
Thbd
thrombomodulin
Disease_progression
ISS
3
137,158,955
137,162,607
RGD:5685035
RGD
G
Tk1
thymidine kinase 1, soluble
ISS
RGD:2317237
RGD
G
Tlr9
toll-like receptor 9
ISS
RGD:5130185
RGD
G
Tnf
tumor necrosis factor
ISS
20
3,661,000
3,663,618
RGD:4142793
RGD
G
Tnf
tumor necrosis factor
ISS
20
3,661,000
3,663,618
RGD:4143264
RGD
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
Severity
ISS
4
162,172,563
162,185,252
RGD:5131202
RGD
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
Disease_progression
ISS
4
162,172,563
162,185,252
RGD:5131156
RGD
G
Tp53
tumor protein p53
ISS
10
56,399,721
56,411,150
RGD:5133242
RGD
G
Tymp
thymidine phosphorylase
ISS
7
127,666,518
127,671,624
RGD:2325156
RGD
Adenocarcinoma, Bronchiolo-Alveolar
G
Egfr
epidermal growth factor receptor
ISS
14
97,617,358
97,788,211
RGD:5131630
RGD
G
Egfr
epidermal growth factor receptor
ISS
14
97,617,358
97,788,211
RGD:5131465
RGD
G
Egr1
early growth response 1
ISS
18
27,343,919
27,346,117
RGD:5131942
RGD
G
Gstp1
glutathione S-transferase pi 1
ISS
1
206,627,398
206,629,866
RGD:4140940
RGD
Carcinoma, Large Cell
G
Met
met proto-oncogene
Severity
ISS
4
43,134,183
43,211,355
RGD:2317441
RGD
G
Prkca
protein kinase C, alpha
ISS
10
97,367,196
97,638,910
RGD:2292463
RGD
G
Strap
serine/threonine kinase receptor associated protein
ISS
4
174,863,502
174,877,750
RGD:1581429
RGD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest